SCHEMBL24767921

SCHEMBL24767921

c1ccc2c(c1)ccc1c2oc2c3cnccc3c3c4ccccc4[nH]c3c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ CYP1A1 P04798 3/20 0.47
▸ CYP1A2 P05177 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ GMNN O75496 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ NR3C1 P04150 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ LCK P06239 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KIT P10721 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24767896 0.83 KDM4E (0.51) KDM4ECYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL19544192 0.81 KIF11 (0.51) KDM4EALDH1A1HPGDKMT2AMEN1
SCHEMBL19786343 0.77 KIF11 (0.54) KMT2APOLBMEN1MAPTRAB9A
SCHEMBL19382947 0.76 KIF11 (0.41) KDM4ECYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL19988718 0.73 GABRA1 (0.70) KDM4ECYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL2627611 0.73 CDK4 (0.65) KDM4ECYP1A2ALDH1A1HPGDKMT2A
SCHEMBL19988527 0.73 MAP3K11 (0.52) KDM4ECYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL19573737 0.72 CDK4 (0.50) KDM4ECYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL19660898 0.70 KIF11 (0.66) KDM4ECYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL25679865 0.70 KIF11 (0.66) KDM4ECYP1A1CYP1A2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, SLCO2A1, SLCO2B1 KDM4E 2549/4885CYP1A1 537/4885CYP1A2 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback